Otolaryngology/Head and Neck (all articles)
M-A | Vestibular suppressants do not reduce symptoms in patients with benign paroxysmal positional vertigo.
16 Dec, 2022 | 13:18h | UTCVestibular suppressants for benign paroxysmal positional vertigo: A systematic review and meta-analysis of randomized controlled trials – Academic Emergency Medicine (link to abstract – $ for full-text)
Cohort Study | Tobacco use and incidence of adverse oral health outcomes.
12 Dec, 2022 | 12:30h | UTCCommentary: Expert reaction to study looking at smoking, vaping and oral health – Science Media Centre
Cohort Study | Lobectomy vs. total thyroidectomy for intermediate-risk papillary thyroid carcinoma with lymph node metastasis.
6 Dec, 2022 | 13:41h | UTCComparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis – JAMA Surgery (free for a limited period)
Invited Commentary: Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis? – JAMA Surgery (free for a limited period)
Commentary on Twitter
Study of patients with papillary thyroid carcinoma and lymph node metastases found that recurrence-free survival was similar after lobectomy and total #thyroidectomy. https://t.co/07mMcczp1T
— JAMA Surgery (@JAMASurgery) December 1, 2022
Case–control study | GLP-1 receptor agonists linked to increased risk of thyroid cancer.
25 Nov, 2022 | 12:42h | UTCGLP-1 Receptor Agonists and the Risk of Thyroid Cancer – Diabetes Care (link to abstract – $ for full-text)
Commentary: GLP-1 receptor agonists associated with thyroid cancer – ACP Internist
WHO report highlights oral health neglect affecting nearly half of the world’s population.
24 Nov, 2022 | 13:36h | UTCNews Release: WHO highlights oral health neglect affecting nearly half of the world’s population – World Health Organization
Commentary: Oral Health Neglect: The Overlooked Crisis Affecting 3.5 Billion People – Health Policy Watch
Commentary on Twitter (thread – click for more)
Good #OralHealth is essential in our daily lives helping us eat, breathe, and speak.
Yet, oral diseases affect nearly 3.5 billion people worldwide. More in WHO’s new Global Oral Health Status Report ?https://t.co/NYOvKYy6Xg pic.twitter.com/zpyI2uqWfT
— World Health Organization (WHO) (@WHO) November 18, 2022
M-A | Prevalence and global estimates of unsafe listening practices in adolescents and young adults.
24 Nov, 2022 | 13:18h | UTCNews Release: 1 billion + young people potentially at risk of hearing loss from loud music – BMJ Newsroom
Commentary from the author on Twitter (with video summary).
Why risk your hearing when its possible to ‘hear for life’?
Listen with care! @WHO study shows that 1 billion young people risk hearing loss from loud music. https://t.co/ziDn5OOoJn
protect your ears by following simple tips for #safelistening @MikkelsenBente_ pic.twitter.com/jvMVGXDpPi— Shelly Chadha (@ShellyChadha1) November 22, 2022
SR | There is insufficient evidence to recommend Ginkgo biloba for tinnitus.
18 Nov, 2022 | 13:19h | UTCGinkgo biloba for tinnitus – Cochrane Library
Summary: Ginkgo biloba herbal supplement for tinnitus – Cochrane Library
M-A | Long-term outcomes of turbinate surgery in patients with allergic rhinitis.
18 Nov, 2022 | 13:09h | UTCLong-term Outcomes of Turbinate Surgery in Patients With Allergic Rhinitis: A Systematic Review and Meta-analysis – JAMA Otolaryngology—Head & Neck Surgery (free for a limited period)
RCT | Effectiveness of tonsillectomy vs. modified uvulopalatopharyngoplasty in patients with tonsillar hypertrophy and sleep apnea.
7 Nov, 2022 | 12:36h | UTCEffectiveness of Tonsillectomy vs Modified Uvulopalatopharyngoplasty in Patients With Tonsillar Hypertrophy and Obstructive Sleep Apnea: The TEAMUP Randomized Clinical Trial – JAMA Otolaryngology—Head & Neck Surgery (free for a limited period)
M-A | Efficacy of laryngeal mask airway against postoperative pharyngolaryngeal complications following thyroid surgery.
1 Nov, 2022 | 12:05h | UTC
2022 ETA Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.
27 Oct, 2022 | 12:33h | UTCCommentary: New EU Guidelines: Individualize Care for Thyroid Cancer in Kids – Medscape (free registration required)
Guidelines for best practice in the audiological management of adults using bimodal hearing configurations.
26 Oct, 2022 | 14:35h | UTC
Commentary on Twitter
Clinics are treating a growing number of patients with greater amounts of residual hearing. These patients often benefit from #BimodalHearing. Check out these new guidelines to learn more: https://t.co/UQUAv8BRE4 #CochlearImplant #HearingAid @wkhealth @lippincott @OandNonline pic.twitter.com/3cpmJgfEc6
— Otology & Neurotology Open (@ONOjournal) July 28, 2022
Systematic Review | Antihistamines to prevent and treat motion sickness.
19 Oct, 2022 | 14:21h | UTCAntihistamines for motion sickness – Cochrane Library
Summary: Antihistamines to prevent and treat motion sickness – Cochrane Library
Commentary on Twitter
New from Cochrane Evidence: Antihistamines are likely to reduce the risk of developing motion sickness in susceptible adults under normal conditions, e.g. traveling by car or boat, but they may be more likely to cause drowsiness than placebo https://t.co/l3gtX9ad7T… pic.twitter.com/EcQZYmwMrU
— Cochrane ENT (@CochraneENT) October 17, 2022
Guideline Summary | Recommendations for care of survivors of head and neck cancer.
7 Oct, 2022 | 14:15h | UTCRecommendations for Care of Survivors of Head and Neck Cancer – JAMA (free for a limited period)
Original Guideline: Head and neck cancer survivorship consensus statement from the American Head and Neck Society – Laryngoscope Investigative Otolaryngology
Related:
American Cancer Society Head and Neck Cancer Survivorship Care Guideline
Outcomes 12 months after temperature-controlled radiofrequency device treatment of the nasal valve for nasal airway obstruction.
26 Sep, 2022 | 11:59h | UTC
M-A of randomized trials | Prophylactic central neck lymph node dissection in low-risk thyroid carcinoma patients does not decrease the incidence of locoregional recurrence.
21 Sep, 2022 | 13:07h | UTCProphylactic Central Neck Lymph Node Dissection in Low-risk Thyroid Carcinoma Patients Does Not Decrease the Incidence of Locoregional Recurrence: A Meta-analysis of Randomized Trials – Annals of Surgery (link to abstract – $ for full-text)
International consensus statement on obstructive sleep apnea.
8 Sep, 2022 | 14:41h | UTCInternational consensus statement on obstructive sleep apnea – Allergy & Rhinology (PDF)
M-A | Hypocalcemia following thyroidectomy among patients who have previously undergone bariatric surgery.
8 Sep, 2022 | 14:25h | UTCHypocalcaemia following thyroidectomy among patients who have previously undergone bariatric surgery: systematic review and meta-analysis – British Journal of Surgery (link to abstract – $ for full-text)
Guideline | Patient preparation and radiation protection guidance for adult patients undergoing radioiodine treatment for thyroid cancer.
1 Sep, 2022 | 11:53h | UTC
RCT | In patients with low-risk nasopharyngeal carcinoma, radiotherapy alone was noninferior to radiotherapy plus concurrent chemoradiotherapy on survival without disease relapse at 3 years.
25 Aug, 2022 | 12:13h | UTCEffect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial – JAMA (free for a limited period)
Video Editor’s Note: Radiotherapy With vs Without Chemoradiotherapy in Low-risk Nasopharyngeal Carcinoma – JAMA
Guidelines for clinical assessment and management of adult cochlear implantation for single-sided deafness.
24 Aug, 2022 | 14:13h | UTC
The contemporary management of cancers of the sinonasal tract in adults.
16 Aug, 2022 | 13:39h | UTC
Systematic Review | Psychological therapies for temporomandibular disorders.
15 Aug, 2022 | 11:39h | UTCPsychological therapies for temporomandibular disorders (TMDs) – Cochrane Library
Consensus Statement | Pharmacological management of allergic rhinitis.
11 Aug, 2022 | 12:10h | UTCRelated:
RCT | Effect of intranasal Dexmedetomidine or Midazolam for premedication on the occurrence of respiratory adverse events in children undergoing tonsillectomy and adenoidectomy.
11 Aug, 2022 | 12:08h | UTCCommentaries:
Dexmedetomidine Cuts Perioperative Respiratory AEs in Tonsillectomy – HealthDay
Commentary on Twitter
Children often required sedatives before surgery due to anxiety and crying. In this RCT, intranasal midazolam increased the incidence of perioperative respiratory adverse events (PRAEs), while intranasal dexmedetomidine reduced PRAEs. #OrigInvestigation https://t.co/5AAILuzstM pic.twitter.com/WejpGkAGGs
— JAMA Network Open (@JAMANetworkOpen) August 9, 2022